Skip to main content

Table 1 Clinicopathological and therapeutic features of patients who underwent duodenopancreatectomy

From: Does intraoperative closed-suction drainage influence the rate of pancreatic fistula after pancreaticoduodenectomy?

Characteristics

Study population

(n = 197)

Passive drainage

(n = 132)

Closed-suction drainage

(n = 65)

 
 

No./mean ± SDa

(%)

No./mean ± SDa

(%)

No./mean ± SDa

(%)

p

Age (years)

66.2 ± 11.8

-

64.8 ± 11.3

-

68.5 ± 11.8

-

0.08

Male

108

(54.8)

70

(53.0)

38

(58.5)

0.47

Body mass index (kg/m2)

25.0 ± 4.3

-

24.7 ± 4.1

-

25.5 ± 4.4

-

0.21

ASAb score

0.31

 1

44

(22.3)

34

(25.0)

10

(15.4)

 2

114

(57.9)

75

(56.8)

39

(60.0)

 3

39

(18.3)

23

(17.4)

16

(24.6)

Chronic pancreatitis

30

(19.8)

19

(14.4)

12

(18.5)

0.46

Pathology

<0.01

 Adenocarcinoma

134

(68.0)

97

(73.5)

37

(56.9)

 Cholangiocarcinoma

7

(3.6)

6

(4.5)

1

(1.5)

 Ampullocarcinoma

6

(3.0)

5

(3.8)

1

(1.5)

 Other

50

(25.4)

24

(18.2)

26

(40.1)

Neoadjuvant treatment

22

(11.2)

13

(9.8)

9

(13.8)

0.40

Pre-operative biliary drainage

93

(47.2)

66

(50.0)

27

(41.5)

0.26

Artery resection

1

(0.5)

1

(0.8)

0

(0)

1.00

Vein resection

38

(19.3)

32

(24.2)

6

(9.2)

0.01

Pylorus preservation

142

(72.1)

106

(80.3)

36

(55.4)

<0.01

Type of pancreatic anastomosis

<0.01

 Pancreaticogastrostomy

97

(49.2)

79

(60.3)

18

(28.1)

 Pancreaticojejunostomy

98

(49.8)

52

(39.7)

46

(71.9)

Soft pancreatic gland texture

28

(14.2)

18

(13.6)

10

(15.4)

0.66

Main pancreatic duct diameter

4.93 ± 2.45

-

5.0 ± 2.3

-

5.1 ± 2.7

-

0.79

Intra-operative blood loss (mL)

685 ± 588

-

664 ± 519

-

728 ± 719

-

0.89

Blood transfusion

44

(22.3)

28

(22.8)

16

(24.6)

0.78

Operative time (minutes)

388 ± 125

-

339 ± 136

-

377 ± 95

-

0.16

Somatostatin analogs

89

45.2

61

47.3

28

43.7

0.65

  1. aStandard deviation
  2. bAmerican Society of Anesthesiology